Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vincristine Induced Neurotoxicity”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT03593304
What this trial is testing

Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients

Who this might be right for
Vincristine Induced NeurotoxicityAcute Lymphoblastic Leukaemia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 40
Early research (Phase 1)Study completedNCT00001689
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Who this might be right for
Acute Lymphocytic LeukemiaLeukemia
National Cancer Institute (NCI) 90
Large-scale testing (Phase 3)Study completedNCT00369564
What this trial is testing

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
University of South Florida 250
Testing effectiveness (Phase 2)Study completedNCT00365768
What this trial is testing

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Columbia University 56
Testing effectiveness (Phase 2)Study completedNCT01399372
What this trial is testing

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Chemotherapeutic Agent ToxicityCognitive/Functional EffectsLymphoma+2 more
Radiation Therapy Oncology Group 91